Anandamide is associated with waist-to-hip ratio but not with Body Mass Index in women with polycystic ovary syndrome
- 1 May 2023
- journal article
- research article
- Published by Edizioni Minerva Medica in Minerva Endocrinology
- Vol. 48 (2) , 150-159
Abstract
Article: Anandamide is associated with waist-to-hip ratio but not with body mass index in women with polycystic ovary syndrome - Minerva Endocrinology 2022 Feb 23 - Minerva Medica - JournalsKeywords
This publication has 38 references indexed in Scilit:
- Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MSJournal of Lipid Research, 2012
- Central Obesity and Survival in Subjects With Coronary Artery DiseaseJACC, 2011
- Impact of Obesity on the Risk for Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2008
- Diagnostic performance of body mass index to detect obesity in patients with coronary artery diseaseEuropean Heart Journal, 2007
- The role of the endocannabinoid system in gametogenesis, implantation and early pregnancyHuman Reproduction Update, 2007
- Review article: The impact of obesity on reproduction in women with polycystic ovary syndromeBJOG: An International Journal of Obstetrics & Gynaecology, 2006
- Plant, Synthetic, and Endogenous Cannabinoids in MedicineAnnual Review of Medicine, 2006
- The endocannabinoid system and its therapeutic exploitationNature Reviews Drug Discovery, 2004
- Obesity and the polycystic ovary syndromeInternational Journal of Obesity, 2002
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992